Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Immunic Inc

IMUX
Current price
1.36 USD -0.01 USD (-0.73%)
Last closed 1.38 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 124 309 016 USD
Yield for 12 month -47.08 %
1Y
3Y
5Y
10Y
15Y
IMUX
21.11.2021 - 28.11.2021

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical trial, for treatment of multiple sclerosis, including relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company is also developing IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York. Address: 1200 Avenue of the Americas, New York, NY, United States, 10036

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-111 000 USD

Last Year

-77 000 USD

Current Quarter

-26 000 USD

Last Quarter

-23 000 USD

Key Figures IMUX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -95 748 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -56.25 %
PEG Ratio
Return On Equity TTM -112.05 %
Wall Street Target Price 11.5 USD
Revenue TTM
Book Value 0.93 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.83 USD
Diluted Eps TTM -1.83 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IMUX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IMUX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:40
Payout Ratio
Last Split Date 15.04.2019
Dividend Date 15.04.2019

Stock Valuation IMUX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.8491
Price Book MRQ 4.4761

Financials IMUX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IMUX

For 52 weeks

0.95 USD 2.78 USD
50 Day MA 1.22 USD
Shares Short Prior Month 2 963 163
200 Day MA 1.26 USD
Short Ratio 12.77
Shares Short 3 005 616
Short Percent 3.37 %

Dynamics of changes in the value of assets

T

TOP

2.50 USD Zhong Yang Financial Group Limited Ordinary Shares -0.06 (-2.16%)
Detailed analytics
7

7643

1 351.00 JPY Daiichi Co Ltd -0.03 (-0.3%)
Detailed analytics
X

XE7C

2.23 EUR Cardiff Oncology Inc +0.04 (+1.59%)
Detailed analytics
C

COLRF

0.00010 USD China Medical & HealthCare Group Limited 0 (0%)
Detailed analytics
4

4783

1 876.00 JPY Nippon Computer Dynamics Co Ltd +0.18 (+1.57%)
Detailed analytics